Your browser doesn't support javascript.
loading
Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49).
Gibson, C Michael; Kumar, Varun; Gopalakrishnan, Lakshmi; Singh, Priyamvada; Guo, Jianping; Kazziha, Samer; Devireddy, Chandan; Pinto, Duane; Marshall, J Jeffrey; Stouffer, George A; Mavromatis, Kreton; Grip, Laura; Bainey, Kevin R.
Afiliação
  • Gibson CM; Cardiovascular Division, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts; TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: mgibson@bidmc.harvard.edu.
  • Kumar V; Cardiovascular Division, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Gopalakrishnan L; Cardiovascular Division, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Singh P; Cardiovascular Division, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Guo J; TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts.
  • Kazziha S; Cardiovascular Division, Crittenton Hospital Medical Center, Rochester, Michigan.
  • Devireddy C; Cardiovascular Division, Emory University School of Medicine, Atlanta, Georgia.
  • Pinto D; Cardiovascular Division, Departments of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Marshall JJ; Cardiovascular Division, Departments of Medicine, Northeast Georgia Heart Center, Gainesville, Georgia.
  • Stouffer GA; McAllister Heart Institute and Division of Cardiology, University of North Carolina, Chapel Hill, North Carolina.
  • Mavromatis K; Cardiovascular Division, Departments of Medicine, Atlanta VA Medical Center, Emory University School of Medicine, Atlanta, Georgia.
  • Grip L; TIMI Study Group, Brigham and Women's Hospital, Boston, Massachusetts.
  • Bainey KR; Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
Am J Cardiol ; 125(4): 485-490, 2020 02 15.
Article em En | MEDLINE | ID: mdl-31870492

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrinolíticos / Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST / Tenecteplase Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrinolíticos / Intervenção Coronária Percutânea / Infarto do Miocárdio com Supradesnível do Segmento ST / Tenecteplase Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Ano de publicação: 2020 Tipo de documento: Article País de publicação: Estados Unidos